Clinical Trials · NCT03971110
A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.
- Phase
- Phase 4
- Recruitment status
- Terminated
- Sponsor
- AstraZeneca
- Enrollment
- 9
- Start date
- Jan 2021
- Locations
- 15 sites, China
- Primary endpoint
- Resectability rate for primary tumour (the resectability will be assessed by central review using a digital rectal examination and confirmed by CT or MRI)